FDA Greenlights Arcellx’s CART-ddBCMA Treatment Trial After Clinical Hold Lifted

Washington, D.C. – Arcellx’s iMMagine-1 Phase II clinical program has received approval from the FDA to resume testing its CART-ddBCMA treatment for patients with relapsed or refractory multiple myeloma, following a temporary hold on the trial earlier this year. The company announced this development on Monday, signaling a positive step forward for the innovative cell … Read more

Garland Greenlights Death Penalty for Buffalo Mass Shooter in Break from Policy Stance

Washington (AP) — After Attorney General Merrick Garland issued a moratorium to halt federal executions a few months into his term, a significant shift in policy was observed. He suspended all federal executions, in stark contrast to the 13 carried out by his predecessor in just six months. The move aligned with President Biden’s pledge … Read more